TheRealWendy
:
Don’t believe the hype. Dexcom took a hit because it missed earnings and it’s competitor capitalized by chumming the press with nonsense. Dexcom is held by Vanguard, BlackRock hedge funds and they have INCREASED positions. Get in now while it’s on fire sale. Also, DXCM is releasing a new OTC product this months and they are already the preferred brand for hospitals across the US.
TheRealWendy : Don’t believe the hype. Dexcom took a hit because it missed earnings and it’s competitor capitalized by chumming the press with nonsense. Dexcom is held by Vanguard, BlackRock hedge funds and they have INCREASED positions. Get in now while it’s on fire sale. Also, DXCM is releasing a new OTC product this months and they are already the preferred brand for hospitals across the US.